LLY
Eli Lilly and Co
Price:  
1,131.42 
USD
Volume:  
4,118,092.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LLY EV/EBITDA

-70.2%
Upside

As of 2026-06-07, the EV/EBITDA ratio of Eli Lilly and Co (LLY) is 30.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LLY's latest enterprise value is 1,103,591.50 mil USD. LLY's TTM EBITDA according to its financial statements is 35,981.20 mil USD. Dividing these 2 quantities gives us the above LLY EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 7.2x - 8.8x 8.1x
Forward P/E multiples 9.1x - 12.6x 11.0x
Fair Price 234.65 - 472.69 337.57
Upside -79.3% - -58.2% -70.2%
1,131.42 USD
Stock Price
337.57 USD
Fair Price

LLY EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-06-05 30.67
2026-06-04 30.51
2026-06-03 29.29
2026-06-02 28.91
2026-06-01 29.38
2026-05-29 29.98
2026-05-28 30.55
2026-05-27 29.40
2026-05-26 28.93
2026-05-22 28.93
2026-05-21 28.32
2026-05-20 27.73
2026-05-19 27.79
2026-05-18 26.92
2026-05-15 27.36
2026-05-14 27.41
2026-05-13 27.64
2026-05-12 26.97
2026-05-11 26.37
2026-05-08 25.88
2026-05-07 26.58
2026-05-06 26.89
2026-05-05 26.94
2026-05-04 26.39
2026-05-01 26.27
2026-04-30 25.52
2026-04-29 23.34
2026-04-28 23.93
2026-04-27 23.78
2026-04-24 24.19
2026-04-23 25.08
2026-04-22 25.18
2026-04-21 24.69
2026-04-20 25.14
2026-04-17 25.32
2026-04-16 24.72
2026-04-15 24.75
2026-04-14 25.20
2026-04-13 25.39
2026-04-10 25.65
2026-04-09 26.06
2026-04-08 26.01
2026-04-07 25.43
2026-04-06 25.32
2026-04-02 25.55
2026-04-01 26.04
2026-03-31 25.13
2026-03-30 24.26
2026-03-27 24.04
2026-03-26 24.54